Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Limited announced an update to its Top 20 Option Holders list and Distribution Schedule, correcting an error related to the expiry date of its Piggyback Options, now set to expire on 1 September 2027. This update ensures accurate information for stakeholders and maintains transparency in the company’s option holdings, which is crucial for investor confidence and market operations.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is a global medical technology company specializing in advanced imaging and artificial intelligence for respiratory care. The company offers a range of software solutions, including the FDA-cleared XV Lung Ventilation Analysis Software and the CT:VQ solution, which enhance lung disease detection and monitoring. These solutions are delivered through a Software-as-a-Service model, integrating into existing hospital infrastructure to improve physician productivity and patient care. The company is committed to redefining respiratory disease understanding and treatment worldwide.
Average Trading Volume: 4,649,380
Technical Sentiment Signal: Buy
Current Market Cap: A$766.7M
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.